1
Stephen D Pacetti, Syed F A Hossainy, Yiwen Tang, Andrew C Tung, Thierry Glauser: Coatings for drug delivery devices having gradient of hydration and methods for fabricating thereof. Advanced Cardiovascular Systems, Squire Sanders & Dempsey, February 12, 2008: US07329413 (25 worldwide citation)

Coatings for implantable medical devices, and methods for fabricating thereof, are provided. The coatings include a first polymer layer and a second polymer layer, where the second polymer has a higher degree of hydration than the first polymer.


2
Yunbing Wang, James Oberhauser, Manish Gada, Thierry Glauser, Vincent Gueriguian, Bethany Steichen, Lothar Kleiner, Xiao Ma: Implantable medical device comprising copolymer of L-lactide with improved fracture toughness. Abbott Cardiovascular Systems, Squire Sanders, February 21, 2012: US08119704 (16 worldwide citation)

The present invention relates to implantable medical devices comprising a L-lactide-constitutional unit-containing copolymer having a wt % percent crystallinity of 40% or less.


3
Lothar W Kleiner, James P Oberhauser, Thierry Glauser, David K Wrolstad, Yunbing Wang: Polymer tube expansion apparatus to maximize fracture toughness. Abbott Cardiovascular Systems, Squire Sanders, November 6, 2012: US08303296 (12 worldwide citation)

Methods of and systems for fabricating a polymeric stent with improved fracture toughness including radial expansion of a polymer tube along its entire length at the same time and fabricating a stent from the expanded tube are disclosed herein.


4
Syed Faiyaz Ahmed Hossainy, Yiwen Tang, Homayon Askaryar, Qing Lin, Thierry Glauser: Methods of forming coatings with a crystalline or partially crystalline drug for implantable medical devices. Abbott Cardiovascular Systems, Squire Sanders, June 17, 2014: US08753709 (12 worldwide citation)

Methods for making coatings on an implantable device, such as a drug-eluting stent. The coatings comprise a polymer and a drug in a crystalline or partially crystalline form. In addition, implantable devices produced by the methods and methods of using the coated implantable devices are described.


5
Syed Faiyaz Ahmed Hossainy, Yiwen Tang, Homayon Askaryar, Qing Lin, Thierry Glauser: Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS. Advanced Cardiovascular Systems, Squires Sanders, October 8, 2013: US08551512 (10 worldwide citation)

Methods for making coatings on an implantable device such as a drug-eluting stent comprising a polymer and nano or microparticles of a drug in slow-dissolving polymorph, implantable devices produced by the methods and methods of using the coatings are provided.


6
Thierry Glauser, Vincent Gueriguian, Bethany Steichen, James Oberhauser, Manish Gada, Lothar Kleiner, Mary Beth Kossuth: Controlling crystalline morphology of a bioabsorbable stent. Abbott Cardiovascular Systems, Squire Sanders, August 6, 2013: US08501079 (8 worldwide citation)

Methods to expand polymer tubing with desirable or optimum morphology and mechanical properties for stent manufacture and fabrication of a stent therefrom are disclosed.


7
Thierry Glauser, Connie S Kwok, Charles D Claude, Eugene T Michal, Yiwen Tang, Irina Astafieva, John Whatley, Stephen D Pacetti, Ashok Shah: Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same. Advanced Cardiovascular Systems, Squire Sanders, November 13, 2012: US08309112 (7 worldwide citation)

A segmented polyurethane and an amphiphilic random or block copolymer are disclosed. The segmented polyurethane and the amphiphilic random or block copolymer can be used for fabricating a coating for an implantable medical device such as a stent.


8
Stephen D Pacetti, Thierry Glauser: Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages. Advanced Cardiovascular Systems, Squire Sanders, January 22, 2013: US08357391 (6 worldwide citation)

Coatings for an implantable medical device and a method of fabricating thereof are disclosed, the coatings including block-polymers comprising at least one poly(hydroxyacid) or poly(hydroxy-alkanoate) block, at least one block of a biologically compatible polymer and a linking moiety.


9
Lothar W Kleiner, James P Oberhauser, Thierry Glauser, David K Wrolstad, Yunbing Wang: Tube expansion process for semicrystalline polymers to maximize fracture toughness. Abbott Cardiovascular Systems, Squire Sanders & Dempsey, September 6, 2011: US08012402 (4 worldwide citation)

Methods of fabricating a polymeric stent with improved fracture toughness including radial expansion of a polymer tube along its entire length at the same time and fabricating a stent from the expanded tube are disclosed herein.


10
Paul Consigny, Thierry Glauser, John Stankus, Stephen Pacetti, Santosh Prabhu: Embolic delivery of therapeutic agents. Abbott Cardiovascular Systems, Squire Sanders, August 20, 2013: US08512737 (4 worldwide citation)

This application is directed to means for embolic delivery of therapeutic agents to an afflicted organ in the body of a patient.